Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	43.99	27.31	18.97
Graham Fair Price	-35.63	1017.70	1581.13
PEG	-63.07	-0.55	-0.34
Price/Book	0.97	1.40	1.38
Price/Cash Flow	-50.38	46.32	-93.36
Prices/Earnings	162.52	32.89	12.53
Price/Sales	11.54	3.16	2.83
Price/FCF	-50.38	46.32	-93.36
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	39.26	0.68	0.49
Operating Margin	-57.56	0.04	0.09
ROA	-60.50	< 0.005	< 0.005
ROE	0.03	0.01	-61.54
ROIC	0.01	< 0.005	-67.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.01	-0.03	54.36
Dividends QOQ	18.44	-0.99	-94.63
EBIT QOQ	-0.35	-0.60	-73.23
EPS QOQ	-0.37	-0.60	-60.99
FCF QOQ	-1.31	3.11	137.31
Revenue QOQ	-0.03	-0.06	-139.99
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.96	30.78	71.39
Days Sales Outstanding (DSO)	34.14	38.69	13.31
Inventory Turnover	5.01	2.92	-41.65
Debt/Capitalization	0.51	0.49	-2.41
Quick Ratio	1.20	1.23	2.26
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2006.26	2082.22	3.79
Cash	1597.92	1671.23	4.59
Capex	-166.74	-137.45	17.56
Free Cash Flow	-29.72	62.78	111.19
Revenue	980.36	921.09	-6.05
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.38	1.39	0.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.84	3.28	15.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating